TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.

Scott T Tagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.